Express News | Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries
Gilead Sciences Signs Licensing Deals With 6 Drugmakers to Manufacture HIV Prevention Drug Lenacapavir
Harris Vs. Trump: 2024 Election Poll Shows Good, Bad News For Each Candidate
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading
Trump Vs. Harris: 2024 Election Betting Odds Show Vice President Maintains Lead As Race Nears One-Month Mark
Top Gap Ups and Downs on Monday: NVO, AZN, HSBC and More
Close Call In Virginia: Recent Poll Shows Harris Barely Leading Trump In Democratic-Leaning State
Voters Warm To Kamala Harris As Election Nears
UBS Group: Harris' victory will be bullish for utility bonds, while Trump will boost energy.
The Head of Credit Strategy at UBS Group stated that if Harris wins the election, it will boost bonds in industries such as utilities. Trump, on the other hand, will boost industries such as energy.
'Big Short' Fame Investor Drops Previous Prediction Of Trump Victory: 'The Market Is Going Straight Down' If Kamala Harris Wins White House And Democrats Sweep Congress
Kamala Harris Underlines Her Support For Second Amendment, Dismisses False Dichotomy Of Gun Control Debate: Jokes To Oprah: 'If Somebody Breaks In My House They Getting Shot'
Kamala Harris Tells Oprah Winfrey She Felt A 'Sense Of Responsibility' After Biden's Sudden Exit: It Came With A 'Sense of Purpose'
Harris In Trouble? New Swing State Poll Shows Trump Gains Ground In Key Battleground Areas For 2024 Election
Donald Trump Now Trails Kamala Harris By 4 Points After 9-Point Election Odds Turnaround In Only 9 Days
Over a hundred former Republican officials have written an open letter supporting Harris: Trump is not suitable to regain the White House.
① These Republican officials have served in institutions such as the White House, Department of Defense, Department of Treasury, Department of State, Department of Justice, Department of Homeland Security, and Congress; ② These officials have expressed that although there may be policy differences with Harris, these concerns seem insignificant compared to the "chaos and unethical behavior" exhibited by Trump.
Dr. Reddy's Laboratories Agreed To Partially Defer A Milestone Payment From Citius Oncology, Inc., Due On September 9, 2024, Upon FDA Approval Of LYMPHIR, Without Penalty, Pending Further Discussions, As Per Their 2021 Asset Purchase Agreement
Showdown at the peak! The first debate of the US election between Hart and Trump has come to an end. Who won, Trump or Harris?
On September 11th, from 9:00 to 10:45 Beijing time, the presidential candidates in the United States - former President Trump and current Vice President Harris - held a televised debate for the US presidential election. This was also the first face-to-face confrontation between the two candidates. In this debate, the two candidates discussed various issues, including the economy, abortion rights, immigration, the Israeli-Palestinian conflict, the Russia-Ukraine conflict, the Afghanistan issue, and climate change.
September Effect: Potential Safe Haven Stocks Amid Market Volatility
Express News | Dr. Reddy's Issues Clarification Regarding Allegations Tied To Engagement With Agora Advisory; Confirms Engagement Of Dhaval Buch From October 2020 To April 2021, Prior To Madhabi Buch's SEBI Chairpersonship; Asserts Compliance With Laws And Denies...
Dr. Reddy's Laboratories Faces GST Penalty